10 completed, 10 recruiting, 5 terminated, 4 unknown. 15 Phase 1, 10 Phase 2, 4 Early Phase 1, 3 Not applicable, 2 Phase 3.
Follow Glioblastoma Multiforme of Brain: new trials by email Literature Review of Glioblastoma Multiforme of Brain trials Research Report on Glioblastoma Multiforme of Brain
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma GLIX1 - Glioblastoma Multiforme of Brain, Glioma | Phase 1 | Recruiting | Tetragon Biosciences Ltd | 30 | 2026-04-20 | 2026-11-04 |
| Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma Ruxolitinib, Temozolomide, Radiation Therapy - Glioblastoma, Brain Cancer | Phase 2 | Recruiting | Baptist Health South Florida | 190 | 2025-12-03 | 2026-10-02 |
| GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma 15.GPC3-CAR T cells - Glioblastoma Multiforme of Brain | Phase 1 | Recruiting | Baylor College of Medicine | 27 | 2025-10-10 | 2026-09-30 |
| Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoing Standard Chemotherapy Focused Ultrasound Next Generation Dome Helmet, Definity® Vial for (Perflutren Lipid Microsphere) Injectable Suspension - GBM, Glioblastoma Multiforme (GBM) | Phase 1 | Recruiting | Sunnybrook Health Sciences Centre | 10 | 2025-06-04 | 2025-09-17 |
| Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma Fluciclovine F18 - Glioblastoma, Recurrent Glioblastoma | Early Phase 1 | Recruiting | Abramson Cancer Center at Penn Medicine | 15 | 2025-05-01 | 2026-09-09 |
| Re-Administration of C134 in Patients With Recurrent GBM (C134-HSV-1) C134 Re-Administration - Recurrent Malignant Glioma, Glioblastoma Multiforme of Brain | Phase 1 | Terminated | University of Alabama at Birmingham | 1 | 2024-06-21 | 2026-01-22 |
| Cisplatin Plus Temozolomide Compared With Temozolomide in Patients With MGMT Promotor Unmethylated Glioblastoma Cisplatin Plus Temozolomide, Temozolomide - Glioblastoma Multiforme of Brain | Phase 1 / Phase 2 | Unknown | Zhongnan Hospital | 60 | 2024-01-01 | 2024-01-02 |
| Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM) TVI-Brain-1, Standard of Care, Radiotherapy - Glioblastoma Multiforme of Brain | Phase 2 / Phase 3 | Active not recruiting | TVAX Biomedical | 120 | 2023-12-27 | 2026-09-29 |
| CAR T Cells in Patients With MMP2+ Recurrent or Progressive Glioblastoma CHM-1101 CAR-T cells - Glioblastoma Multiforme of Brain | Phase 1 | Terminated | Chimeric Therapeutics | 1 | 2023-06-06 | 2026-06-29 |
| Intracavitary Photodynamic Therapy as an Adjuvant to Resection of Glioblastoma or Gliosarcoma Using IV Photobac® photochemotherapy using 3-(1-Butyloxy)ethyl-3-deacetyl-bacteriopurpurin-18-n-butylimide methyl ester(Photobac®) - Glioblastoma Multiforme of Brain, Glioma, Sarcomatous | Phase 1 | Unknown | Photolitec LLC | 30 | 2023-04-11 | 2023-04-13 |
| Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM) Laparoscopically harvested omental tissue autograft - Glioma, Glioma, Malignant | Not applicable | Recruiting | Northwell Health | 10 | 2023-04-04 | 2026-06-01 |
| A Clinical Study of Intratumoral MVR-C5252 (C5252) in Patients With Recurrent or Progressive Glioblastoma C5252 - Solid Tumor, Glioblastoma | Phase 1 | Unknown | ImmVira Pharma Co. Ltd | 51 | 2023-03-15 | 2022-10-12 |
| The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302) Re-resection, Temozolomide, Lomustine - Glioblastoma, Glioblastoma Multiforme | Recruiting | Jasper Gerritsen | 464 | 2023-01-01 | 2024-02-28 | |
| The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202) Tumor resection, Tumor biopsy - Glioblastoma, Glioblastoma, IDH-wildtype | Recruiting | Jasper Gerritsen | 564 | 2023-01-01 | 2023-11-27 | |
| The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma Awake mapping under local anesthesia, Asleep mapping under general anesthesia, Resection under general anesthesia without mapping - Glioblastoma, IDH-wildtype, Glioblastoma | Recruiting | Erasmus Medical Center | 225 | 2023-01-01 | 2024-02-22 | |
| Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: A Phase 0 Clinical Trial Posaconazole Pill - Glioblastoma, Glioblastoma Multiforme | Early Phase 1 | Terminated | Milton S. Hershey Medical Center | 7 | 2022-05-13 | 2026-01-23 |
| Neuro-pharmacological Properties of Repurposed Ketoconazole in Glioblastomas Ketoconazole - Glioblastoma, Glioblastoma Multiforme | Early Phase 1 | Terminated | Milton S. Hershey Medical Center | 1 | 2022-05-11 | 2026-01-07 |
| [18F]FPIA PET-CT in Glioblastoma Multiforme (GBM) Positron Emission Tomography-Computerised Tomography (PET-CT) - Glioblastoma Multiforme of Brain | Completed | Imperial College London | 3 | 2022-04-19 | 2025-04-09 | |
| The Impact of Resistance ExerciSe on Muscle Mass in GlioblaSToma Survivors Circuit-based resistance exercise (CRT) - Glioblastoma Multiforme of Brain, Brain Cancer | Not applicable | Enrolling by invitation | Nova Scotia Health Authority | 24 | 2022-03-01 | 2026-05-29 |
| Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma Niraparib, Radiation therapy - Glioblastoma, Glioblastoma Multiforme | Early Phase 1 | Active not recruiting | Nader Sanai | 42 | 2021-10-29 | 2026-03-09 |
Showing 20 of 34. Sign in to see all of them.
Glioblastoma (21) · Brain Neoplasms (13) · Glioma (7) · Astrocytoma (3) · Recurrence (2) · Gliosarcoma (1) · Motor Activity (1) · Muscular Diseases (1) · Postoperative Complications (1)
Neoplasms (25) · Neoplasms by Histologic Type (23) · Neoplasms, Germ Cell and Embryonal (23) · Neoplasms, Glandular and Epithelial (23) · Neoplasms, Nerve Tissue (23) · Neoplasms, Neuroepithelial (23) · Neuroectodermal Tumors (23) · Astrocytoma (18) · Glioma (16) · Brain Diseases (13) · Central Nervous System Diseases (13) · Central Nervous System Neoplasms (13) · Neoplasms by Site (13) · Nervous System Diseases (13) · Nervous System Neoplasms (13)
Temozolomide (6) · Radiotherapy (3) · Chlorotoxin (1) · Cisplatin (1) · Diet, Ketogenic (1) · Drug Therapy (1) · Evoked Potentials (1) · Immunotherapy (1) · Ketoconazole (1) · Lomustine (1) · Oncolytic Virotherapy (1) · Positron Emission Tomography Computed Tomography (1) · Re-Irradiation (1) · Standard of Care (1) · Therapies, Investigational (1)
Jasper Gerritsen (3) · Milton S. Hershey Medical Center (2) · Northwell Health (2) · University of Alabama at Birmingham (2) · Abramson Cancer Center at Penn Medicine (1) · Baptist Health South Florida (1) · Baylor College of Medicine (1) · Beijing Tiantan Hospital (1) · Burzynski Research Institute (1) · Chimeric Therapeutics (1) · Clinique Neuro-Outaouais (1) · Emory University (1) · Erasmus Medical Center (1) · ImmVira Pharma Co. Ltd (1) · Imperial College London (1)
United States (21) · Belgium (5) · Germany (4) · Netherlands (4) · Switzerland (4) · Canada (3) · China (2) · Iran (1) · United Kingdom (1)
Jasper Gerritsen, MD PhD (3) · James Markert, MD (2) · John Boockvar, MD (2) · Ali Nabavizadeh, MD (1) · Alireza Mansouri (1) · Alireza Mansouri, MD (1) · Arnaud Vincent, MD PhD (1) · Ganesh Rao, MD (1) · Gary Wood, PhD (1) · Ghazaleh Tabatabai, Prof (1) · Hui-Kuo Shu, MD, PhD (1) · Kazem Anvari, M.D. (1) · Lung-Ji Chang, PhD (1) · Mahdi Silanian Toosi, M.D. (1)
PMID 12436090, PMID 12743250, PMID 12893641, PMID 15717053, PMID 15792886, PMID 18798293, PMID 19664713, PMID 19682584, PMID 19833552, PMID 21924290, PMID 22037136, PMID 22629405, PMID 23388348, PMID 25117977, PMID 31676314, PMID 33292598, PMID 34290067, PMID 34604752, PMID 35507403, PMID 35569489, PMID 35861778, PMID 36549916, PMID 36617554, PMID 39260848, PMID 404164, PMID 42401550, PMID 42494994
F30CA206291 (1), P30CA138292 (1), R01CA222903 (1), R03CA255992 (1), R21NS100244 (1), R44CA247127 (1), U01CA172027 (1)